And to determine the underlying molecular mechanisms by which NSC-exos protect against AD pathology, including the regulation of Aβ and p-tau, reduction of inflammatory mediators, and modulation of associated molecular processes. This evidence concerns the gene MAPT and Alzheimer disease.